Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rank

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
The British Journal of Surgery|May 1, 1985
Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancerJ Kjaergaard, M Blichert-Toft, J A Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|September 15, 2000
Impact of axillary dissection on staging and regional control in breast tumors < or = 10 mm--the DBCG experience. The Danish Breast Cancer Cooperative Group (DBCG), Rigshisoutalet, Copenhagen, DenmarkC K Axelsson, F Rank, M Blichert-Toft, et al.
Clinical Physiology and Functional Imaging|June 24, 2005
Radiation doses to staff involved in sentinel node operations for breast cancerT L Klausen, A H Chakera, E Friis, et al.
Journal of Medical Screening|October 9, 2002
Early outcome of mammography screening in Copenhagen 1991-99I Vejborg, A H Olsen, M-B Jensen, et al.
Scandinavian Journal of Rheumatology|January 1, 1985
Flexor tenosynovitis (FTS): a risk indicator of abnormal glucose toleranceI Leden, G Jonsson, S Larsen, et al.
The American Journal of Pathology|February 1, 1989
Immunoreactive opioid peptides in human breast cancerL Scopsi, E Balslev, N Brünner, et al.
Tumori|August 31, 1992
Histopathologic classification of breast cancer in Sweden and Italy: a comparison between two pathologistsD Palli, S Bianchi, F Linell, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2001
Urokinase plasminogen activator is localized in stromal cells in ductal breast cancerB S Nielsen, M Sehested, S Duun, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patientsH T Mouridsen, C Rose, H Brincker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancerH Brincker, C Rose, F Rank, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
The British Journal of Surgery|May 1, 1985
Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancerJ Kjaergaard, M Blichert-Toft, J A Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|September 15, 2000
Impact of axillary dissection on staging and regional control in breast tumors < or = 10 mm--the DBCG experience. The Danish Breast Cancer Cooperative Group (DBCG), Rigshisoutalet, Copenhagen, DenmarkC K Axelsson, F Rank, M Blichert-Toft, et al.
Clinical Physiology and Functional Imaging|June 24, 2005
Radiation doses to staff involved in sentinel node operations for breast cancerT L Klausen, A H Chakera, E Friis, et al.
Journal of Medical Screening|October 9, 2002
Early outcome of mammography screening in Copenhagen 1991-99I Vejborg, A H Olsen, M-B Jensen, et al.
Scandinavian Journal of Rheumatology|January 1, 1985
Flexor tenosynovitis (FTS): a risk indicator of abnormal glucose toleranceI Leden, G Jonsson, S Larsen, et al.
The American Journal of Pathology|February 1, 1989
Immunoreactive opioid peptides in human breast cancerL Scopsi, E Balslev, N Brünner, et al.
Tumori|August 31, 1992
Histopathologic classification of breast cancer in Sweden and Italy: a comparison between two pathologistsD Palli, S Bianchi, F Linell, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2001
Urokinase plasminogen activator is localized in stromal cells in ductal breast cancerB S Nielsen, M Sehested, S Duun, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patientsH T Mouridsen, C Rose, H Brincker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancerH Brincker, C Rose, F Rank, et al.
Pageof 8